Female Sexual Dysfunction as a Warning Sign of Chronic Disease Development

Stasi, Vincenza Di; Verde, Nunzia; Maseroli, Elisa; Scavello, Irene; Cipriani, Sarah; Todisco, Tommaso; Maggi, Mario; Vignozzi, Linda

doi:10.1007/s11930-019-00229-4

Cited by 10 publications

(4 citation statements)

References 130 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Since sexual dysfunctions in rheumatic diseases are often multifactorial, integrating biopsychological and socio-environmental components is of vital importance [ 41 ]. Therefore, we performed bivariant and multivariant analyses with several variables of interest that could potentially be associated with the presence of sexual dysfunctions.…”

Section: Discussionmentioning

confidence: 99%

Sexual function in patients with idiopathic inflammatory myopathies: a cross-sectional study

et al. 2021

View full text Add to dashboard Cite

Objectives To date, there is almost no information concerning the sexual health of patients with idiopathic inflammatory myopathies (IIM). This cross-sectional study aimed to compare sexual function in patients with IIM to age-/sex-matched healthy controls (HC) and determine the potential impact of clinical features on sexual function. Methods In total, 122 women (61 with IIM, 61 age-matched HC) and 22 men (11 with IIM, 11 age-matched HC) aged 18–80 years completed gender specific selection of 11 well-established and validated questionnaires assessing sexual health and function (Female Sexual Function Index, Brief Index of Sexual Function for Women, Sexual Function Questionnaire, Sexual Quality of Life Questionnaire–Female, International Index of Erectile Function, Male Sexual Health Questionnaire, Sexual Quality of Life Questionnaire–Male). Results were compared between patients and HC and correlated with selected disease-related features. Results The prevalence of sexual dysfunction in IIM was 59% in women (vs 40% in HC), and 64% (vs 9% in HC) in men. Men and women with IIM reported significantly impaired sexual function compared with sex-/age-matched HC. Decreased sexual function was associated with muscle weakness, disability, physical inactivity, fatigue, depression, and decreased quality of life. Conclusions Our results suggest that sexual dysfunction is common among IIM patients and more attention should be paid to this aspect of the disease.

show abstract

Section: Discussionmentioning

confidence: 99%

Sexual function in patients with idiopathic inflammatory myopathies: a cross-sectional study

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Several general medical conditions, including neurologic, oncologic, and metabolic disorders, may represent risk factors for HSDD. Indeed, chronic diseases interfere with sexual function through multiple mechanisms, including fatigue and the psychological burden of a lifelong progressive diagnosis [27]. Psychiatric disorders, such as depression, are also major determinants of low sexual desire and display a bidirectional relationship, with depressive symptoms conferring a 50-70% increased risk of HSDD and HSDD being associated with a 130-210% increased risk of depression [22,28].…”

Section: Prevalence and Leading Etiologies Of Hsddmentioning

confidence: 99%

Female Sexual Dysfunctions: A Clinical Perspective on HSDD, FAD, PGAD, and FOD

Graziottin

Maseroli

Vignozzi

2022

Practical Clinical Andrology

View full text Add to dashboard Cite

The multidimensionality and interpersonal dimension of human sexuality make the study of female sexual dysfunction (FSD) a challenge. The aspiration to pursue a patient-centered, holistic approach collides with the need to establish commonly accepted diagnostic criteria for different disturbances in sexual functioning, involving one or multiple phases of the sexual response cycle and pain associated with sexual activity. According to recently proposed classifications, which are continuously evolving, the most relevant FSDs include hypoactive sexual desire disorder, female arousal disorder, persistent genital arousal disorder, and female orgasm disorder. The present chapter aims to provide a clinical perspective on these disorders by reviewing the most recent evidence on the pathophysiology, definitions, prevalence, leading etiologies, diagnostic tools, and key therapeutic approaches. Sexual pain-related conditions will be reviewed in another chapter.It is evident that a gender bias still exists, with prominent biological etiologies of FSDs being neglected and understudied at the expense of psychodynamic and relational determinants. Moreover, classifications should serve to advocate the advancement of our knowledge of female sexual functioning. This process goes through the practical translation of the updated nosology in a language that is intelligible to primary healthcare providers all over the world, and ultimately, to women.

show abstract

“…Previous studies disclosed that migraine as a chronic pain can disrupt the quality of life for women and cause female sexual dysfunction [16] . This may be caused by organic reasons, or less likely caused by psychogenic illness [17] .…”

Section: Introductionmentioning

confidence: 99%

Sexual dysfunction in migraine-affected women: A prospective cross-sectional controlled study

Kamel,

Dantata,

Halilu

et al. 2024

European Journal of Obstetrics & Gynecology and Reproductiv

View full text Add to dashboard Cite

Female Sexual Dysfunction as a Warning Sign of Chronic Disease Development

Cited by 10 publications

References 130 publications

Sexual function in patients with idiopathic inflammatory myopathies: a cross-sectional study

Sexual function in patients with idiopathic inflammatory myopathies: a cross-sectional study

Female Sexual Dysfunctions: A Clinical Perspective on HSDD, FAD, PGAD, and FOD

Sexual dysfunction in migraine-affected women: A prospective cross-sectional controlled study

Contact Info

Product

Resources

About